These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26670486)

  • 21. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
    Sun Y; Chen X; Chen Z; Ma X; Li D; Shang P; Qian A
    Arch Oral Biol; 2015 Feb; 60(2):282-92. PubMed ID: 25463906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New roles of filopodia and podosomes in the differentiation and fusion process of osteoclasts.
    Song RL; Liu XZ; Zhu JQ; Zhang JM; Gao Q; Zhao HY; Sheng AZ; Yuan Y; Gu JH; Zou H; Wang QC; Liu ZP
    Genet Mol Res; 2014 Jul; 13(3):4776-87. PubMed ID: 25062413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
    Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH
    Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-
    Ahn SH; Chen Z; Lee J; Lee SW; Min SH; Kim ND; Lee TH
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
    Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
    Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the bone resorption supernatant from RAW264.7 osteoclast on the osteogenic activity of mouse MC3T3-E1 cell].
    Chen LL; Wang K; Zhang J; Wu YM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jan; 47(1):32-7. PubMed ID: 22490219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts.
    Ahn SJ; Baek JM; Cheon YH; Park SH; Lee MS; Oh J; Kim JY
    Am J Chin Med; 2015; 43(4):715-29. PubMed ID: 26119955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascorbic acid inhibits osteoclastogenesis of RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand (RANKL) in vitro.
    Xiao XH; Liao EY; Zhou HD; Dai RC; Yuan LQ; Wu XP
    J Endocrinol Invest; 2005 Mar; 28(3):253-60. PubMed ID: 15952411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H; Zhao L; Cao H; Chen A; Xiao J
    FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts.
    Akiyama T; Dass CR; Shinoda Y; Kawano H; Tanaka S; Choong PF
    J Pharm Pharmacol; 2010 Apr; 62(4):470-6. PubMed ID: 20604836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
    Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
    Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
    Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
    Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10.
    Tanaka K; Yamagata K; Kubo S; Nakayamada S; Sakata K; Matsui T; Yamagishi SI; Okada Y; Tanaka Y
    Bone; 2019 Nov; 128():115034. PubMed ID: 31421252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.